TY  - GEN
N2  - Discussions about controlled substance medications can cause distress because patients may feel frustrated and abandoned as practice changes, while providers struggle with the responsibility of safely managing symptoms. This distress can negatively impact the therapeutic relationship, lead to high levels of provider burn-out and distress, and contribute to patient dissatisfaction. This quality improvement (QI) project details the development of a CSRC including coordinating interested participants and formalizing logistics for case referral and review process at a metropolitan nonprofit community health organization. The aim of this QI project was to provide clinical support for challenging cases involving CS treatment planning through a committee of interprofessional staff offering individualized evidence-based recommendations and resources.
DO  - 10.6083/f7623d209
DO  - DOI
AB  - Discussions about controlled substance medications can cause distress because patients may feel frustrated and abandoned as practice changes, while providers struggle with the responsibility of safely managing symptoms. This distress can negatively impact the therapeutic relationship, lead to high levels of provider burn-out and distress, and contribute to patient dissatisfaction. This quality improvement (QI) project details the development of a CSRC including coordinating interested participants and formalizing logistics for case referral and review process at a metropolitan nonprofit community health organization. The aim of this QI project was to provide clinical support for challenging cases involving CS treatment planning through a committee of interprofessional staff offering individualized evidence-based recommendations and resources.
AD  - Oregon Health and Science University
T1  - A quality improvement project: developing a controlled substance review committee at a federally qualified health center
DA  - 2022
AU  - Gardner, Natasha A.
L1  - https://digitalcollections.ohsu.edu/record/9708/files/Gardner.Avalon.2022.pdf
PB  - Oregon Health and Science University
PY  - 2022
ID  - 9708
L4  - https://digitalcollections.ohsu.edu/record/9708/files/Gardner.Avalon.2022.pdf
KW  - Controlled Substances
KW  - Quality Improvement
KW  - Advisory Committees
KW  - controlled substance committee
KW  - health care outcome assessment
TI  - A quality improvement project: developing a controlled substance review committee at a federally qualified health center
Y1  - 2022
L2  - https://digitalcollections.ohsu.edu/record/9708/files/Gardner.Avalon.2022.pdf
LK  - https://digitalcollections.ohsu.edu/record/9708/files/Gardner.Avalon.2022.pdf
UR  - https://digitalcollections.ohsu.edu/record/9708/files/Gardner.Avalon.2022.pdf
ER  -